---
document_datetime: 2023-09-21 17:15:00
document_pages: 1
document_pathfilename: www.ema.europa.eu/en/documents/all-authorised-presentations/orfadin-epar-all-authorised-presentations_en.pdf
document_name: orfadin-epar-all-authorised-presentations_en.pdf
version: success
processing_time: 1.0005048
conversion_datetime: 2025-12-23 03:44:55.714731
docling_version:
  docling-serve: 1.9.0
  docling-jobkit: 1.8.0
  docling: 2.64.1
  docling-core: 2.55.0
  docling-ibm-models: 3.10.3
  docling-parse: 4.7.2
  python: cpython-313 (3.13.11)
  plaform: macOS-26.2-arm64-arm-64bit-Mach-O
---
| MA (EU) number   | Invented name   | Strength   | Pharmaceutical form   | Route of administration   | Immediate Packaging   | Content   | Pack size                             |
|------------------|-----------------|------------|-----------------------|---------------------------|-----------------------|-----------|---------------------------------------|
| EU/1/04/303/001  | Orfadin         | 2 mg       | Hard capsule          | Oral use                  | Bottle (HDPE)         |           | 60 Capsules                           |
| EU/1/04/303/002  | Orfadin         | 5 mg       | Hard capsule          | Oral use                  | Bottle (HDPE)         |           | 60 Capsules                           |
| EU/1/04/303/003  | Orfadin         | 10 mg      | Hard capsule          | Oral use                  | Bottle (HDPE)         |           | 60 Capsules                           |
| EU/1/04/303/004  | Orfadin         | 20 mg      | Hard capsule          | Oral use                  | Bottle (HDPE)         |           | 60 Capsules                           |
| EU/1/04/303/005  | Orfadin         | 4 mg/ml    | Oral suspension       | Oral use                  | Bottle (glass)        | 90 ml     | 1 bottle +1 adaptor + 3 oral syringes |